NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2019 Wong YC, Luk K, Purtell K, Burke Nanni S, Stoessl AJ, Trudeau LE, Yue Z, Krainc D, Oertel W, Obeso JA, Volpicelli-Daley LA. Neuronal vulnerability in Parkinson disease: Should the focus be on axons and synaptic terminals? Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31483900 DOI: 10.1002/mds.27823   
2019 Mishra A, Singh S, Tiwari V, Bano S, Shukla S. Dopamine Receptor D1 Agonism Induces Dynamin Related Protein-1 Inhibition to Improve Mitochondrial Biogenesis and Dopaminergic Neurogenesis in Rat Model of Parkinson's disease. Behavioural Brain Research. 112304. PMID 31626851 DOI: 10.1016/j.bbr.2019.112304   
2019 Krashia P, Cordella A, Nobili A, La Barbera L, Federici M, Leuti A, Campanelli F, Natale G, Marino G, Calabrese V, Vedele F, Ghiglieri V, Picconi B, Di Lazzaro G, Schirinzi T, et al. Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's disease. Nature Communications. 10: 3945. PMID 31477726 DOI: 10.1038/s41467-019-11928-w   
2019 Ke M, Chong CM, Su H. Using induced pluripotent stem cells for modeling Parkinson's disease. World Journal of Stem Cells. 11: 634-649. PMID 31616540 DOI: 10.4252/wjsc.v11.i9.634   
2019 Zhao G, Zhang DY, Liu XL, Qiao DC. [Dopamine D2 receptor may be involved in the regulation of cortical-striatum synaptic transmission and autonomic activity in PD mice by exercise]. Sheng Li Xue Bao : [Acta Physiologica Sinica]. 71: 547-554. PMID 31440751   
2019 Kim DH, Choi JJ, Park BJ. Herbal medicine (Hepad) prevents dopaminergic neuronal death in the rat MPTP model of Parkinson's disease. Integrative Medicine Research. 8: 202-208. PMID 31467840 DOI: 10.1016/j.imr.2019.07.005   
2019 Cai R, Zhang Y, Simmering JE, Schultz JL, Li Y, Fernandez-Carasa I, Consiglio A, Raya A, Polgreen PM, Narayanan NS, Yuan Y, Chen Z, Su W, Han Y, Zhao C, et al. Enhancing glycolysis attenuates Parkinson's disease progression in models and clinical databases. The Journal of Clinical Investigation. PMID 31524631 DOI: 10.1172/JCI129987   
2019 Maulik M, Mitra S, Basmayor AM, Lu B, Taylor BE, Bult-Ito A. Genetic Silencing of Fatty Acid Desaturases Modulates α-Synuclein Toxicity and Neuronal Loss in Parkinson-Like Models of . Frontiers in Aging Neuroscience. 11: 207. PMID 31447665 DOI: 10.3389/fnagi.2019.00207   
2019 Ghaisas S, Langley MR, Palanisamy BN, Dutta S, Narayanaswamy K, Plummer PJ, Sarkar S, Ay M, Jin H, Anantharam V, Kanthasamy A, Kanthasamy AG. MitoPark Transgenic Mouse Model Recapitulates the Gastrointestinal Dysfunction and Gut-Microbiome Changes of Parkinson's Disease. Neurotoxicology. PMID 31505196 DOI: 10.1016/j.neuro.2019.09.004   
2019 Mercado G, Brundin P. Lots of Movement in Gut and Parkinson's Research. Trends in Endocrinology and Metabolism: Tem. PMID 31473011 DOI: 10.1016/j.tem.2019.08.001   
2019 Stayte S, Laloli KJ, Rentsch P, Lowth A, Li KM, Pickford R, Vissel B. The kainate receptor antagonist UBP310 but not single deletion of GluK1, GluK2, or GluK3 subunits, inhibits MPTP-induced degeneration in the mouse midbrain. Experimental Neurology. 113062. PMID 31513786 DOI: 10.1016/j.expneurol.2019.113062   
2019 De Luca R, Latella D, Maggio MG, Di Lorenzo G, Maresca G, Sciarrone F, Militi D, Bramanti P, Calabrò RS. Computer assisted cognitive rehabilitation improves visuospatial and executive functions in Parkinson's disease: Preliminary results. Neurorehabilitation. PMID 31498141 DOI: 10.3233/NRE-192789   
2019 Lee EH, Kim SM, Kim CH, Pagire SH, Pagire HS, Chung HY, Ahn JH, Park CH. Dopamine neuron induction and the neuroprotective effects of thyroid hormone derivatives. Scientific Reports. 9: 13659. PMID 31541140 DOI: 10.1038/s41598-019-49876-6   
2019 Nagao KJ, Patel NJ. From medications to surgery: advances in the treatment of motor complications in Parkinson's disease. Drugs in Context. 8: 212592. PMID 31516532 DOI: 10.7573/dic.212592   
2019 Shams R, Banik NL, Haque A. Calpain in the cleavage of alpha-synuclein and the pathogenesis of Parkinson's disease. Progress in Molecular Biology and Translational Science. 167: 107-124. PMID 31601400 DOI: 10.1016/bs.pmbts.2019.06.007   
2019 Parra I, Martínez I, Ramírez-García G, Tizabi Y, Mendieta L. Differential Effects of LPS and 6-OHDA on Microglia's Morphology in Rats: Implications for Inflammatory Model of Parkinson's Disease. Neurotoxicity Research. PMID 31478124 DOI: 10.1007/s12640-019-00104-z   
2019 Chen QQ, Haikal C, Li W, Li JY. Gut Inflammation in Association With Pathogenesis of Parkinson's Disease. Frontiers in Molecular Neuroscience. 12: 218. PMID 31572126 DOI: 10.3389/fnmol.2019.00218   
2019 Espinoza S, Scarpato M, Damiani D, Managò F, Mereu M, Contestabile A, Peruzzo O, Carninci P, Santoro C, Papaleo F, Mingozzi F, Ronzitti G, Zucchelli S, Gustincich S. SINEUP Non-coding RNA Targeting GDNF Rescues Motor Deficits and Neurodegeneration in a Mouse Model of Parkinson's Disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 31495777 DOI: 10.1016/j.ymthe.2019.08.005   
2019 Keane PC, Hanson PS, Patterson L, Blain PG, Hepplewhite P, Khundakar AA, Judge SJ, Kahle P, LeBeau FEN, Morris CM. Trichloroethylene and its metabolite TaClo lead to degeneration of substantia nigra dopaminergic neurones: Effects in wild type and human A30P mutant α-synuclein mice. Neuroscience Letters. 134437. PMID 31422098 DOI: 10.1016/j.neulet.2019.134437   
2019 Jiang X, Jin T, Zhang H, Miao J, Zhao X, Su Y, Zhang Y. Current Progress of Mitochondrial Quality Control Pathways Underlying the Pathogenesis of Parkinson's Disease. Oxidative Medicine and Cellular Longevity. 2019: 4578462. PMID 31485291 DOI: 10.1155/2019/4578462   
2019 Mei M, Zhou Y, Liu M, Zhao F, Wang C, Ding J, Lu M, Hu G. Antioxidant and anti-inflammatory effects of Dexrazoxane on dopaminergic neuron degeneration in rodent models of Parkinson's disease. Neuropharmacology. 107758. PMID 31494143 DOI: 10.1016/j.neuropharm.2019.107758   
2019 Giuliano C, Siani F, Mus L, Ghezzi C, Cerri S, Pacchetti B, Bigogno C, Blandini F. Neuroprotective effects of lignan 7-hydroxymatairesinol (HMR/lignan) in a rodent model of Parkinson's disease. Nutrition (Burbank, Los Angeles County, Calif.). 69: 110494. PMID 31586482 DOI: 10.1016/j.nut.2019.04.006   
2019 Paul SS, Dibble LE, Olivier GN, Walter C, Duff K, Schaefer SY. Dopamine replacement improves motor learning of an upper extremity task in people with Parkinson disease. Behavioural Brain Research. 112213. PMID 31526767 DOI: 10.1016/j.bbr.2019.112213   
2019 Ardashov OV, Pavlova AV, Mahato AK, Sidorova Y, Morozova EA, Korchagina DV, Salnikov GE, Genaev AM, Patrusheva OS, Li-Zhulanov NS, Tolstikova TG, Volcho KP, Salakhutdinov NF. A Novel Small Molecule Supports the Survival of Cultured Dopamine Neurons and May Restore the Dopaminergic Innervation of the Brain in the MPTP Mouse Model of Parkinson's Disease. Acs Chemical Neuroscience. PMID 31464415 DOI: 10.1021/acschemneuro.9b00396   
2019 Nadeau J, Smith T, Lamontagne-Proulx J, Bourque M, Al Sweidi S, Jayasinghe D, Ritchie S, Di Paolo T, Soulet D. Neuroprotection and immunomodulation in the gut of parkinsonian mice with a plasmalogen precursor. Brain Research. 1725: 146460. PMID 31525350 DOI: 10.1016/j.brainres.2019.146460   
2019 Balke D, Tatenhorst L, Dambeck V, Ribas VT, Vahsen BF, Michel U, Bähr M, Lingor P. AAV-Mediated Expression of Dominant-Negative ULK1 Increases Neuronal Survival and Enhances Motor Performance in the MPTP Mouse Model of Parkinson's Disease. Molecular Neurobiology. PMID 31446549 DOI: 10.1007/s12035-019-01744-0   
2019 Mou L, Ding W, Fernandez-Funez P. Open questions on the nature of Parkinson's disease: from triggers to spreading pathology. Journal of Medical Genetics. PMID 31484719 DOI: 10.1136/jmedgenet-2019-106210   
2019 Sharma S, Awasthi A, Singh S. Altered Gut Microbiota and Intestinal Permeability in Parkinson's disease: Pathological highlight to Management. Neuroscience Letters. 134516. PMID 31560998 DOI: 10.1016/j.neulet.2019.134516   
2019 Tan Y, Ke M, Huang Z, Chong CM, Cen X, Lu JH, Yao X, Qin D, Su H. Hydroxyurea Facilitates Manifestation of Disease Relevant Phenotypes in Patients-Derived IPSCs-Based Modeling of Late-Onset Parkinson's Disease. Aging and Disease. 10: 1037-1048. PMID 31595201 DOI: 10.14336/AD.2018.1216   
2019 Oh YS, Kim JS, Yoo SW, Hwang EJ, Lyoo CH, Lee KS. Gender difference in the effect of uric acid on striatal dopamine in early Parkinson's disease. European Journal of Neurology. PMID 31446637 DOI: 10.1111/ene.14070   
2019 Cacabelos R, Carrera I, Alejo R, Fernández-Novoa L, Cacabelos P, Corzo L, Rodríguez S, Alcaraz M, Tellado I, Cacabelos N, Pego R, Carril JC. Pharmacogenetics of Atremorine-Induced Neuroprotection and Dopamine Response in Parkinson's Disease. Planta Medica. PMID 31559607 DOI: 10.1055/a-1013-7686   
2019 Foffani G, Trigo-Damas I, Pineda-Pardo JA, Blesa J, Rodríguez-Rojas R, Martínez-Fernández R, Obeso JA. Focused ultrasound in Parkinson's disease: A twofold path toward disease modification. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31412430 DOI: 10.1002/mds.27805   
2019 Kim T, Song S, Park Y, Kang S, Seo H. HDAC Inhibition by Valproic Acid Induces Neuroprotection and Improvement of PD-like Behaviors in LRRK2 R1441G Transgenic Mice. Experimental Neurobiology. 28: 504-515. PMID 31495079 DOI: 10.5607/en.2019.28.4.504   
2019 Beck G, Singh A, Zhang J, Potts LF, Woo JM, Park ES, Mochizuki H, Mouradian MM, Papa SM. Role of striatal ΔFosB in l-Dopa-induced dyskinesias of parkinsonian nonhuman primates. Proceedings of the National Academy of Sciences of the United States of America. PMID 31455727 DOI: 10.1073/pnas.1907810116   
2019 O'Neill E, Yssel JD, McNamara C, Harkin A. Pharmacological targeting of β -adrenoceptors is neuroprotective in the LPS inflammatory rat model of Parkinson's disease. British Journal of Pharmacology. PMID 31506926 DOI: 10.1111/bph.14862   
2019 Datta I, Mekha SR, Kaushal A, Ganapathy K, Razdan R. Influence of intranasal exposure of MPTP in multiple doses on liver functions and transition from non-motor to motor symptoms in a rat PD model. Naunyn-Schmiedeberg's Archives of Pharmacology. PMID 31468077 DOI: 10.1007/s00210-019-01715-1   
2019 Gupta HV. Re-Emergent Kinetic Tremor in Parkinson's Disease. Tremor and Other Hyperkinetic Movements (New York, N.Y.). 9. PMID 31498336 DOI: 10.7916/tohm.v0.660   
2019 Hanssen H, Steinhardt J, Münchau A, Al-Zubaidi A, Tzvi E, Heldmann M, Schramm P, Neumann A, Rasche D, Saryyeva A, Voges J, Galazky I, Büntjen L, Heinze HJ, Krauss JK, et al. Cerebello-striatal interaction mediates effects of subthalamic nucleus deep brain stimulation in Parkinson's disease. Parkinsonism & Related Disorders. PMID 31494048 DOI: 10.1016/j.parkreldis.2019.09.003   
2019 Carroll CB, Webb D, Stevens KN, Vickery J, Eyre V, Ball S, Wyse R, Webber M, Foggo A, Zajicek J, Whone A, Creanor S. Simvastatin as a neuroprotective treatment for Parkinson's disease (PD STAT): protocol for a double-blind, randomised, placebo-controlled futility study. Bmj Open. 9: e029740. PMID 31594876 DOI: 10.1136/bmjopen-2019-029740   
2019 Mallet N, Delgado L, Chazalon M, Miguelez C, Baufreton J. Cellular and Synaptic Dysfunctions in Parkinson's Disease: Stepping out of the Striatum. Cells. 8. PMID 31470672 DOI: 10.3390/cells8091005   
2019 Wei H, Zhao J, Zhan L, Zhou Y. Risk Factors and Metabolism of Different Brain Regions by Positron Emission Tomography in Parkinson Disease with Disabling Dyskinesia. Current Neurovascular Research. PMID 31622205 DOI: 10.2174/1567202616666191009102112   
2019 Faynveitz A, Lavian H, Jacob A, Korngreen A. Proliferation of Inhibitory Input to the Substantia Nigra in Experimental Parkinsonism. Frontiers in Cellular Neuroscience. 13: 417. PMID 31572130 DOI: 10.3389/fncel.2019.00417   
2019 Ren C, Ding Y, Wei S, Guan L, Zhang C, Ji Y, Wang F, Yin S, Yin P. G2019S Variation in LRRK2: An Ideal Model for the Study of Parkinson's Disease? Frontiers in Human Neuroscience. 13: 306. PMID 31551736 DOI: 10.3389/fnhum.2019.00306   
2019 Mosley RL, Lu Y, Olson KE, Machhi J, Yan W, Namminga KL, Smith JR, Shandler SJ, Gendelman HE. A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson's Disease. Frontiers in Cellular Neuroscience. 13: 421. PMID 31619964 DOI: 10.3389/fncel.2019.00421   
2019 Yu Y, Lang XY, Li XX, Gu RZ, Liu QS, Lan R, Qin XY. 2,3,5,4'-Tetrahydroxystilbene-2-O-β-d-glucoside attenuates MPP+/MPTP-induced neurotoxicity in vitro and in vivo by restoring the BDNF-TrkB and FGF2-Akt signaling axis and inhibition of apoptosis. Food & Function. PMID 31482900 DOI: 10.1039/c9fo01309a   
2019 Krack P, Volkmann J, Tinkhauser G, Deuschl G. Deep Brain Stimulation in Movement Disorders: From Experimental Surgery to Evidence-Based Therapy. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31580535 DOI: 10.1002/mds.27860   
2019 Yu HX, Guo MR, Li G, Zhang B. Association between fatigue and motor progression in Parkinson's disease in southern Chinese. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. PMID 31485861 DOI: 10.1007/s10072-019-04059-z   
2019 Hyam JA, Roy HA, Huang Y, Martin S, Wang S, Rippey J, Coyne TJ, Stewart I, Kerr G, Silburn P, Paterson DJ, Aziz TZ, Green AL. Cardiovascular autonomic responses in patients with Parkinson disease to pedunculopontine deep brain stimulation. Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society. PMID 31493114 DOI: 10.1007/s10286-019-00634-8   
2019 Kalyani HHN, Sullivan KA, Moyle G, Brauer S, Jeffrey ER, Kerr GK. Impacts of dance on cognition, psychological symptoms and quality of life in Parkinson's disease. Neurorehabilitation. PMID 31561398 DOI: 10.3233/NRE-192788   
2019 Maitra U, Scaglione MN, Chtarbanova S, O'Donnell JM. Innate immune responses to paraquat exposure in a Drosophila model of Parkinson's disease. Scientific Reports. 9: 12714. PMID 31481676 DOI: 10.1038/s41598-019-48977-6